Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001434031 | SCV001636831 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-09-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001544639 | SCV001763810 | likely benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420980 | SCV002681729 | likely benign | Cardiovascular phenotype | 2021-03-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001796494 | SCV002034695 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001544639 | SCV002035428 | likely benign | not provided | no assertion criteria provided | clinical testing |